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Previewsrelevance. A therapeutically important
implication of the study is that heteromer
complexes may provide unique pharma-
cological targets to control a limited set
of functions within a much broader re-
ceptor signaling system. While it has
been difficult to address the short-term
physiological contributions of hetero-
mers, the extent to which heteromer sig-
naling mechanisms contribute to overall
physiological homeostasis over ex-
tended time intervals may be an ever
more intractable problem. For example,
in congenic mice lacking the GHSR1a,
no obvious differences in body weight
and energy expenditure were observable
between control and knockout genotypes
(Sun et al., 2008). On the basis of the
present study the knockouts would also
be expected to lack D2R-GHSR1a-
mediated signaling relevant to appetite
control.
Nonetheless, the D2R-GHSR1a inter-
action described here may have addi-
tional interesting implications for studies
of the dopamine system. Brain dopamine
is involved in the control of many physio-
logical functions including locomotion,
cognition, emotion, and affect, as well
as rewardmechanisms. Dopamine recep-
tors have been some of the first GPCRs
for which allosteric interactions between
heteromers have been postulated tocontribute to function (Fuxe et al., 2010).
A series of recent studies have suggested
that the ‘‘central’’ ghrelin system might
be involved in the control of reward-
seeking behaviors for food, alcohol, and
drugs of abuse by modulating the dopa-
minergic reward pathway from the ventral
tegmental area to the nucleus accum-
bens. Notably, in these animal studies,
ghrelin is invariably injected into various
brain areas to engage the GHSR1a.
However, administration of GHSR1a
antagonists alone has been shown to
reduce preference, intake, and reward
for food, as well as for alcohol, cocaine,
and amphetamine (reviewed in Dickson
et al., 2011). Thus, if D2R-GHSR1a het-
eromers similar to those described by
Kern et al. (2012) exist in the reward
circuit, it would provide not only a poten-
tial mechanism for the ‘‘ghrelinergic’’
effects on reward but also a new para-
digm for the rational development of
therapeutic interventions for abnormal
reward-seeking behaviors.REFERENCES
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In this issue of Neuron, Nicolas et al. (2012) show that JAK2/STAT3 signaling, a canonical pathway for trans-
mitting information from the cell membrane to the nucleus, is critical for NMDAR-LTD, even in the absence of
new DNA transcription.A major goal of neuroscience is to eluci-
date the molecular mechanisms medi-
ating the different forms and phases oflong-term synaptic plasticity that are
thought to underlie learning and memory.
Although many forms of synaptic plas-ticity have been described, four have
been the most widely studied: (1) NMDA
receptor (NMDAR)-dependent, transient, January 26, 2012 ª2012 Elsevier Inc. 211
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Previewsearly long-term potentiation (LTP), (2)
NMDAR-dependent, persistent late LTP
that requires new protein synthesis, (3)
mGluR-dependent long-term depression
(LTD) that also requires new synthesis,
and (4) NMDAR-dependent LTD. A
current challenge to the field is to deter-
mine how these four forms of plasticity
might mediate different aspects of
behavior in the hopes of finding simple
rules that may reframe the psychology of
memory in neurophysiological andmolec-
ular terms. This requires understanding
the core molecular mechanisms of these
long-term synapticmodifications in detail.
The molecular mechanisms for any
long-term form of synaptic plasticity can
be divided into three phases: induction,
triggering the plasticity; maintenance,
sustaining it over time; and expression,
transducing the mechanism of mainte-
nance into a change in synaptic trans-
mission. From the point of view of the
search for the physical substrates of
memory, the heart of the matter is
maintenance. In recent years, significant
progress has been made toward under-
standing the maintenance of the two
protein synthesis-dependent forms of
synaptic plasticity. Whereas induction
involves scores of signaling molecules,
the critical requirement for new protein
synthesis in the transition to maintenance
constrains the complexity of the signaling
network involved in sustaining modified
synaptic transmission in the maintenance
phase. For example, in late LTP, PKMz,
a protein kinase C isoform that is uniquely
synthesized as an autonomously active
kinase by strong afferent stimulation, is
the only kinase that has been found to
maintain increases in synaptic transmis-
sion from hours to days after induction
(Sacktor, 2011). Because PKMz is not
involved in the maintenance of LTD, phar-
macological and genetic tools that inhibit
the kinase and block or reverse late LTP
have been used to demonstrate a role
for late-LTP maintenance in several forms
of long-term memory (Sacktor, 2011).
Analogously, researchers are hot on the
trail of a few suspects that are newly
synthesized in mGluR-LTD, including
arc, STEP, and MAP1b, which may main-
tain this form of synaptic depression
(Lu¨scher and Huber, 2010).
In contrast, the core mechanisms that
maintain the forms of synaptic plasticity212 Neuron 73, January 26, 2012 ª2012 Elsethat rely entirely on posttranslational
modifications have been harder to pin
down. An important mechanism for early
LTP is phosphorylation by protein kinases
that alters the configurations of postsyn-
aptic scaffolding proteins, such as trans-
membrane AMPA receptor regulatory
proteins (TARPs) (Tomita et al., 2005), to
increase the number of AMPARs at post-
synaptic sites. But dozens of kinases
have been implicated in early LTP, and it
has been challenging to distinguish the
essential kinases mediating the poten-
tiation from the kinases that regulate or
modulate this core mechanism. Without
this knowledge, it has been difficult to
evaluate whether the maintenance of
early LTP, which can last from 1 to 3 hr
depending on the stimulation protocol,
is due to the persistence of kinase
activity, the phosphorylated state of the
scaffolding proteins, or a change in the
binding affinity of the scaffolding proteins
that is triggered, but not sustained, by
phosphorylation. In contrast, the rapid
reversal of established late LTP by in-
hibitors of PKMz indicates that the per-
sistent activity of the kinase, elevated
by translation stimulation, maintains the
potentiation.
The molecular mechanisms of the
NMDAR-dependent form of LTD have
been particularly difficult to unravel. LTD
was discovered in 1978 (Dunwiddie and
Lynch, 1978), a few years after the
discovery of LTP, with interest rapidly
expanding in the 1990s, when an
NMDAR-dependent form was shown to
be induced in CA1 pyramidal cells of
hippocampal slices by a few minutes of
moderate, 1–3 Hz afferent synaptic stimu-
lation of Schaffer collateral/commissural
fibers (Dudek and Bear, 1992; Mulkey
and Malenka, 1992). The most widely
studied form of NMDAR-LTD does not
require new protein synthesis for several
hours (but an even more persistent,
protein synthesis-dependent form in-
duced by repeated bursts of stimulation
has also been described [Sajikumar and
Frey, 2004]). NMDAR-LTD shares certain
mechanisms of expression with mGluR-
LTD, such as endocytic removal of
postsynaptic AMPARs mediated by
BRAG2 (Scholz et al., 2010). Yet, the early
induction mechanisms seem different.
Notably, mGluR-LTD induction involves
tyrosine phosphatases (Moult et al.,vier Inc.2008), whereas NMDAR-LTD induction
depends on the serine/threonine phos-
phatases, calcineurin and protein phos-
phatase 1 (Mulkey et al., 1994). Key
mechanisms of NMDAR-LTD mainte-
nance are missing.
The paper by Nicolas et al. (2012)
provides potentially important clues. By
using a combination of biochemical,
pharmacological, and genetic tools, they
show that downstream of the initial in-
duction by phosphatases lies JAK2, a
tyrosine kinase that plays a critical role in
immunological signaling, cell growth and
survival, and the unrestrained growth of
cancer cells (Levy and Darnell, 2002).
The role of JAK2 is specific to NMDAR-
LTD and not to mGluR-LTD, LTP, or
even the activity-dependent reversal of
LTP, known as depotentiation, which
also requires NMDAR activation.
Although JAK2 can phosphorylate a
number of substrates, its best-studied
targets from immunology and cancer
research are the STATs, a family of
transcription factors (Levy and Darnell,
2002). JAK/STAT signaling is among the
most rapid means by which cells can
send signals from the plasma membrane
to the nucleus. Nicolas et al. (2012) show
that STAT3, an isoform particularly abun-
dant at synapses, is the critical down-
stream target in NMDAR-LTD.
So, by its location deeper than the
previously known induction mechanisms,
the JAK/STAT pathway may get us closer
to the central mystery of NMDAR-LTD:
the maintenance mechanism that keeps
its synaptic depression going. Yet here,
too, lies an enigma. STATs are transcrip-
tion factors. But Nicolas et al. (2012)
show that the persistence of LTD does
not need transcription. Indeed, NMDAR-
LTD does not need a nucleus at all,
because NMDAR-LTD can be induced
and maintained for at least 3 hr in syn-
apses in a surgically isolated CA1 radia-
tum, from which the pyramidal cell bodies
have been removed. Moreover, inhibitors
of STAT3 dimerization, a key step in its
activation that leads to its translocation
to the nucleus, prevent NMDAR-LTD,
but an inhibitor of STAT3 binding to DNA
does not.
What roles does STAT3 play other
than as a transcription factor? Very few
have been described, despite the volumi-
nous work on the JAK/STAT pathway in
Neuron
Previewsimmunology and cancer. One line of
research, however, suggests that STAT3
regulates tubulin dynamics by binding to
stathmin, which interacts with tubulin
(Gao and Bromberg, 2006). This suggests
a role in intracellular trafficking. As
mentioned, STAT3 phosphorylation by
JAK in the cytosol of nonneural cells leads
to STAT3 dimerization that then translo-
cates to the nucleus. Although its function
in NMDAR-LTD does not require DNA
binding, Nicolas and colleagues show
that STAT3 nonetheless translocates to
the nucleus of neurons when synapses
are stimulated in NMDAR-LTD. Perhaps
it is not the arrival at the nucleus, but the
transport away from the synapse, that
reflects the importance of STAT3 in
NMDAR-LTD. In nonneural cells, STAT3
transcriptional signaling by activated re-
ceptors is initiated by receptor-mediated
endocytosis and trafficking of the tran-
scription factor in endosomes through
the cytosol to the perinuclear region (Bild
et al., 2002). Perhaps in neurons, this
pathway, triggered by STAT dimerization,
is also used to transport both STAT and
other proteins, including AMPARs, away
from the synapse.Whether the JAK2/STAT3 pathway is
close to the maintenance mechanism of
NMDAR-LTD or not, the agents that
Nicolas et al. (2012) use, many of them
developed to suppress the growth of
cancer cells driven by persistent JAK2/
STAT3 signaling (Levy and Darnell,
2002), can now be used as specific
agents to test the role of NMDAR-LTD in
behavior. Indeed, there are already indi-
cations in Alzheimer’s disease mouse
models that JAK plays a role in spatial
working memory (Chiba et al., 2009)—
intriguingly, one of the types of memory
not mediated by PKMz (Sacktor, 2011).
When the complex memories of behaving
animals can be reframed as the functions
of the elementary molecules maintaining
LTPs and LTDs at synapses in specific
circuits of the brain, a major promise of
neuroscience will be fulfilled.REFERENCES
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